SCN5A and cardiac arrhythmia: DCM patients with variants in the SCN5A gene exhibit a phenotype associated with significant arrhythmias and poor response to HF therapy, while treatment with sodium channel blocking drugs reduces the amount of ectopy and normalizes LVEF [40].